Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase Two Clinical Trial of Buspirone Therapy in Localization-Related Epilepsy

NCT01496612 is registered in ClinicalTrials.gov with National Institute of Neurological Disorders and Stroke (NINDS) as lead sponsor.

NCT NCT01496612
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01496612 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase Two Clinical Trial of Buspirone Therapy in Localization-Related Epilepsy
Lead sponsor
National Institute of Neurological Disorders and Stroke (NINDS)
Phase
Phase 2
Overall status
Terminated
Start date
November 22, 2011
Completion date
April 19, 2016
Enrollment
9 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anxiety disorder, depression, epilepsy, partial epilepsy, seizures